Cavitary Disease and Quantitative Sputum Bacillary Load in Cases of Pulmonary Tuberculosis-Reference-Cited by-同舟云学术

Cavitary Disease and Quantitative Sputum Bacillary Load in Cases of Pulmonary Tuberculosis

Published:2007-12 Issue:12 Volume:45 Page:4064-4066
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Palaci Moises¹,Dietze Reynaldo¹,Hadad David Jamil¹,Ribeiro Fabiola Karla Corrêa¹,Peres Renata Lyrio¹,Vinhas Solange Alves¹,Maciel Ethel Leonor Noia¹,do Valle Dettoni Valdério¹,Horter Libby²,Boom W. Henry²,Johnson John L.²,Eisenach Kathleen D.³

Affiliation:

1. Núcleo de Doenças Infecciosas, Centro de Ciências da Saúde, Universidade Federal do Espírito Santo, Vitória, Brazil

2. Department of Medicine, Division of Infectious Diseases, Case Western Reserve University School of Medicine and University Hospitals Case Medical Center, Cleveland, Ohio

3. Departments of Pathology and Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, Arkansas

Abstract

ABSTRACT We examined sputum bacterial loads in adults with newly diagnosed tuberculosis using quantitative culture and time-until-positive (DTP) culture in BACTEC 460. Patients with cavitary disease had higher CFU levels than those without cavities and shorter DTPs. Within radiographic strata of moderately and far advanced tuberculosis, higher CFU counts were associated with cavitary disease.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.01780-07

Reference19 articles.

1. Andreu, J., J. Caceres, E. Pallisa, and M. Martinez-Rodriguez. 2004. Radiological manifestations of pulmonary tuberculosis. Eur. J. Radiol.51:139-149.

2. Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial

3. The tubercle bacillus in the pulmonary lesion of man: histobacteriology and its bearing on the therapy of pulmonary tuberculosis. 1955

4. Canetti, G. 1965. Present aspects of bacterial resistance in tuberculosis. Am. Rev. Respir. Dis.92:687-703.

5. Safety and Bactericidal Activity of Rifalazil in Patients with Pulmonary Tuberculosis

Cited by 139 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction and Validation of a Nomogram to Identify the Risk of Cavitation in Pulmonary Tuberculosis;Infection and Drug Resistance;2024-07

2. A blood-based 3-gene signature score for therapeutic monitoring in patients with pulmonary tuberculosis;Tuberculosis;2024-07

3. C-reactive protein-based tuberculosis triage testing: a multi-country diagnostic accuracy study;2024-04-24

4. Diagnostic algorithm allows for a scientifically robust and reliable retrospective diagnosis using textual evidence from mid-19th century Basel, Switzerland;International Journal of Paleopathology;2024-03

5. Radiographic characteristics of rifampicin-resistant tuberculosis in the STREAM stage 1 trial and their influence on time to culture conversion in the short regimen;BMC Infectious Diseases;2024-01-30